Standard biomarkers of AD neuropathology (e.g., cerebrospinal diagnostic measures of Ab42/phospho tau or amyloid positron emission tomography) were not systematically measured in the present Nold and ADD participants, so only the strongest and most robust results could emerge at the group level. Here, MAPT is linked to Alzheimer disease.